Higuchi Satoshi, Kabeya Yusuke, Matsushita Kenichi, Tachibana Keisei, Kawachi Riken, Takei Hidefumi, Suzuki Yutaka, Abe Nobutsugu, Imanishi Yorihisa, Moriyama Kiyoshi, Yorozu Tomoko, Saito Koichiro, Sugiyama Masanori, Kondo Haruhiko, Yoshino Hideaki
Division of Cardiology, Department of Internal Medicine II, Kyorin University School of Medicine, Tokyo, Japan.
Division of Cardiology, Department of Internal Medicine II, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka City, Tokyo, 181-8611, Japan.
BMC Cardiovasc Disord. 2018 Jun 26;18(1):127. doi: 10.1186/s12872-018-0862-9.
A previous retrospective cohort study established the relationship between perioperative atrial fibrillation (POAF) and subsequent mortality and stroke. However, the details regarding the cause of death and etiology of stroke remain unclear.
The prospective cohort study of surveillance for perioperative atrial fibrillation recurrence in major non-cardiac surgery for malignancy (PREDICT AF RECURRENCE) registry is an ongoing prospective cohort study to elucidate the long-term recurrence rate and the clinical impact of new-onset POAF in the setting of head and neck, non-cardiac thoracic, and abdominal surgery for malignancy. In this study, cardiologists collaborate with a surgical team during the perioperative period, carefully observe the electrocardiogram (ECG) monitor, and treat arrhythmia as required. Furthermore, patients who develop new-onset POAF are followed up using a long-term Holter ECG monitor, SPIDER FLASH-t AFib, to assess POAF recurrence.
Even if patients with malignancy survive by overcoming the disease, they may die from any preventable cardiovascular diseases. In particular, those with POAF may develop cardiogenic stroke in the future. Because details of the natural history of patients with POAF remain unclear, investigating the need to continue anticoagulation therapy for such patients is necessary. This study will provide essential information on the recurrence rate of POAF and new insights into the prediction and treatment of POAF.
University Hospital Medical Information Network Clinical Trial Registry (UMIN-CTR): UMIN000016146 ; Data of Registration: January 7, 2015.
先前的一项回顾性队列研究确定了围手术期房颤(POAF)与随后的死亡率和中风之间的关系。然而,关于死亡原因和中风病因的细节仍不清楚。
恶性肿瘤非心脏大手术围手术期房颤复发监测前瞻性队列研究(PREDICT AF RECURRENCE)登记处是一项正在进行的前瞻性队列研究,旨在阐明头颈、非心脏胸部和腹部恶性肿瘤手术中新发POAF的长期复发率及其临床影响。在本研究中,心脏病专家在围手术期与手术团队合作,仔细观察心电图(ECG)监测器,并根据需要治疗心律失常。此外,对新发POAF的患者使用长期动态心电图监测器SPIDER FLASH-t AFib进行随访,以评估POAF复发情况。
即使患有恶性肿瘤的患者通过战胜疾病存活下来,他们也可能死于任何可预防的心血管疾病。特别是,那些患有POAF的患者未来可能会发生心源性中风。由于POAF患者自然病史的细节仍不清楚,因此有必要研究此类患者继续抗凝治疗的必要性。本研究将提供有关POAF复发率的重要信息,并为POAF的预测和治疗提供新的见解。
大学医院医学信息网络临床试验注册中心(UMIN-CTR):UMIN000016146;注册日期:2015年1月7日。